Protein Corona of 60nm Silver Nanoparticles
Ontology highlight
ABSTRACT:
OTHER RELATED OMICS DATASETS IN: MODEL1109130000MODEL1909260003MODEL1909260004MODEL1703310000MODEL1909260005MODEL1909260006MODEL1311110000MODEL1311110001
INSTRUMENT(S):
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Blood Plasma
SUBMITTER: 
Vladimir Gorshkov
LAB HEAD: Frank Kjeldsen
PROVIDER: PXD007648 | Pride | 2019-01-23
REPOSITORIES: Pride
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| PPD_MQContRev.fasta | Fasta | |||
| TempA1_1.mzML | Mzml | |||
| TempA1_1.mzid.gz | Mzid | |||
| TempA1_1.pride.mgf.gz | Mgf | |||
| TempA1_1.raw | Raw |
Items per page: 5 1 - 5 of 486 |
Similar Datasets
Project description:Recognition of the protein corona, a layer of adsorbed protein around nanosystems, is necessary for a better understanding of bio-nano interaction. This study first compares different experimental methods for PLGA nanoparticles protein corona isolation, then investigated the biological identity and fingerprint profile of adsorbed proteins on variously pegylated PLGA-based nanoparticles using microfiltration as an ideal isolation method coupled with proteomics. The total proteins identified in the corona of nanoparticles with different compositions were classified based on their abundance and gene-ontology. Lastly, measurements of nanoparticles absorption by macrophages showed a strong association with the characteristics of the protein corona.
2025-11-04 | PXD061055 | Pride
Project description:Recognition of the protein corona, a layer of adsorbed protein around nanosystems, is necessary for a better understanding of bio-nano interaction. This study first compares different experimental methods for PLGA nanoparticles protein corona isolation, then investigated the biological identity and fingerprint profile of adsorbed proteins on variously pegylated PLGA-based nanoparticles using microfiltration as an ideal isolation method coupled with proteomics. The total proteins identified in the corona of nanoparticles with different compositions were classified based on their abundance and gene-ontology. Lastly, measurements of nanoparticles absorption by macrophages showed a strong association with the characteristics of the protein corona.
2025-11-04 | PXD068289 | Pride
Project description:Identification of corona proteins in serum and plasma of healthy donors
2019-01-14 | PXD011781 | Pride
Project description:In the rapidly evolving field of nanomedicine, understanding the interactions between nanoparticles and biological systems is crucial. A pivotal aspect of these interactions is the formation of a protein corona when nanoparticles are exposed to biological fluids, which significantly influences their behavior and functionality. This study introduces an advanced capillary isoelectric focusing-tandem mass spectrometry (cIEF-MS/MS) platform designed to enhance top-down proteomic analysis of nanoparticle protein coronas. By employing a novel 'sandwich' injection method, our cIEF-MS/MS system significantly reduces analysis time to 30 minutes per run, compared to traditional methods, taking over an hour. This method allows for the rapid, reproducible, and automated profiling of complex protein coronas, identifying over 70 distinct proteoforms per analysis from human plasma-incubated polystyrene nanoparticles. The system’s impressive high-throughput capability and precision in detecting post-translational modifications provide deep insights into the proteomic landscape, unveiling potential biomarkers for various diseases. Our findings augment the understanding of nanoparticle-protein interactions and open new avenues for developing targeted nanomedicine drug delivery systems and diagnostic tools. This study sets a new standard in nanoparticle corona research, promising significant advancements in the field.
2025-11-21 | PXD052764 | Pride
Project description:We designed three types of nanoparticles with different lipid compositions, each exhibiting distinct tumor accumulation efficiencies. By isolating the protein corona formed on these nanoparticles in mouse plasma, we performed mass spectrometry to characterize the differential protein adsorption profiles. This analysis allowed us to identify key proteins potentially responsible for enhancing tumor accumulation of nanoparticles.
2025-07-21 | PXD063915 | Pride
Project description:The protein corona, a layer of biomolecules—primarily proteins—that adsorb to nanoparticle (NP) surfaces in biological fluids, critically affects NP safety and their therapeutic and diagnostic functions. Additionally, the protein corona effectively reduces proteome complexity and the dynamic range of protein concentrations in blood plasma and other complex fluids. By suppressing highly abundant proteins, the protein corona enhances the potential for biomarker discovery across diverse health conditions, thereby advancing diagnostic and therapeutic applications. Traditionally, protein corona studies have relied on mass spectrometry (MS)-based bottom-up proteomics (BUP) to analyze corona composition. However, BUP approaches do not accurately identify specific proteoforms—distinct molecular variants of proteins—within the corona. This limitation impedes the nanomedicine field’s ability to precisely predict the biological fate and pharmacokinetics of nanomedicines, as well as their effectiveness in early-stage biomarker discovery and disease detection. Here, we present protocols utilizing capillary zone electrophoresis (CZE)-MS-based top-down proteomics (TDP) to characterize the proteoform landscape of the protein corona. Our procedures detail the recovery of intact proteoforms from NP surfaces and the measurement of these proteoforms using CZE-MS/MS and CZE-high-field asymmetric waveform ion mobility spectrometry (FAIMS)-MS/MS. The entire workflow is completed within three to four days. Implementing this protocol offers mechanistic insights into how proteoforms modulate NP–bio interactions, enabling the nanomedicine community to acquire more comprehensive protein corona profiles. This advancement has the potential to significantly enhance the diagnostic and therapeutic efficacy of nanomedicine technologies.
2025-09-08 | PXD060784 | Pride
Project description:We are human embryologists from center for reproductive medicinel of Anhui Provincial Hospital Affiliated to Anhui Medical University, and we have the expertise to do all that properly in humans. By deep sequencing, the current experiment determined the miRNA profile of two intrafollicular somatic cell types: CRCs and COCs, isolated from women undergoing controlled ovarian stimulation and in vitro fertilization treatment. Ovarian follicles, which are a densely-packed shell of granulosa cells that contains an immature or mature oocyte, are above all responsible for the development, maturation, and release of mature egg for fertilization. They are also responsible for synthesizing and secreting hormones that are essential for follicular development, menstrual and estrous cycle, maintenance of the reproductive tracts and their functions, development of female secondary sex characteristics, and metabolism. During folliculogenesis, ovarian granulosa cells surrounding the oocyte differentiate into mural granulosa cells, involved in gonadal steroidogenesis, and into cumulus cells, which are ovulated with the oocyte at ovulation. These cumulus cells derive from the same population of early follicles, but differentiate into two distinct groups of cells: 1) Those directly lie on the zona pellucida are composed of the so called corona radiata cells.(CRCs) 2) The other group surrounds the CRCs and consists of more numerous cells, forming the so called cumulus oophorus cells (COCs). In the present study, we described the miRNA expression profile to characterize the ensemble of both known and novel miRNAs expressed in CRCs, as well as in COCs, by using high-throughput Solexa technology.
2014-07-14 | E-MTAB-2264 | biostudies-arrayexpress
Project description:Nanoparticles exposed to biological fluids are rapidly surrounded by proteins. It is known that this formed protein corona influences the interplay of nanoparticles with cells or tissue barriers. In this study, we report the impact of a formed human plasma protein corona on the transfer of 80 nm polystyrene (PS) nanoparticles across the human placenta. We used the human ex-vivo placental perfusion model, as it reflects the intact and physiological tissue barrier between mother and unborn. Our results show an enhanced transfer of polystyrenes, exposed to human plasma, across the placenta compared to bovine serum albumin which served as control setting. We isolated nanoparticles before and after tissue exposure and analyzed their protein corona via shotgun proteomics and LC-MS/MS. The corona profile of particles that crossed the placenta highlighted several proteins as possible drivers for elevated tissue transfer. Subsequently two distinct proteins, human albumin and immunoglobulin G, were selected and incubated with the nanoparticles to form a sole protein corona. Strikingly, the protein corona formed by albumin induced significantly the transfer of polystyrenes across the tissue as compared to corona formed by immunoglobulins. To conclude, our study provides a comparative analysis between different formed protein coronas on nanoparticles and a corona dependent transfer behavior of polystyrenes across placental tissue. Our findings suggest that protein corona analyses of nanoparticles might help to understand better their properties at biological barriers.
2020-08-19 | PXD018160 | Pride
Project description:Proteogenomics studies generate hypotheses on protein function and provide genetic evidence for drug target prioritization. Most previous work has been conducted using affinity-based proteomics approaches. These technological face challenges, such as uncertainty regarding target identity, non-specific binding, and handling of variants that affect epitope affinity binding. Mass spectrometry (MS)-based proteomics can overcome some of these challenges. Here we report a pQTL study using the Proteograph™ Product Suite workflow (Seer, Inc.) where we quantify over 18,000 unique peptides from nearly 3,000 proteins in more than 320 blood samples from a multi-ethnic cohort in a bottom-up, peptide-centric, MS-based proteomics approach. We identify 184 protein-altering variants (PAVs) in 137 genes that are significantly associated with their corresponding variant peptides, confirming target specificity of co-associated affinity binders, identifying putatively causal cis-encoded proteins and providing experimental evidence for their presence in blood, including proteins that may be inaccessible to affinity-based proteomics.
2023-12-19 | PXD042852 | Pride
Project description:The protein corona, a dynamic biomolecular layer that forms on nanoparticle (NP) surfaces upon exposure to biological fluids is emerging as a valuable diagnostic tool for improving plasma proteome coverage analyzed by liquid chromatography-mass spectrometry (LC-MS/MS). Here, we show that spiking phosphatidylcholine into plasma can induce diverse protein corona patterns on otherwise identical NPs, significantly enhancing the depth of plasma proteome profiling. This significant achievement is made utilizing only a single NP type and one small molecule to analyze a single plasma sample, setting a new standard in proteomic depth of the plasma sample. Given the critical role of plasma proteomics in biomarker discovery and disease monitoring, we anticipate widespread adoption of this methodology for identification and clinical translation of proteomic biomarkers into FDA approved diagnostics.
2024-10-15 | PXD053359 | Pride